Chapter 1064 Medicine Soars

As the protagonist of the celebration banquet, Liu Mingyu received a toast can be imagined.

Alima and Brother Xiao Ma wanted to get Liu Mingyu drunk, but the final result was naturally that the two horses were rarely drunk, but Liu Mingyu was still in high spirits.

Liu Mingyu, who has undergone three genetic evolutions and used points to strengthen himself to the peak state, how could he be afraid of a little alcohol.

With Liu Mingyu's current physical fitness, there is simply no wine that can pour him down.

After the alcohol entered Liu Mingyu's body, it was absorbed and turned into a kind of energy that was hidden in his body.

He now belongs to the real thousand cups not drunk.

At the beginning, it was just two horses and two people to persuade the drink. When it came to the back, the people around saw that Liu Mingyu was so massive, and they all participated.

The end result was that all the people around him were drunk. Fortunately, this was the hotel. Zhang Guoqing also considered that some people might need accommodation, so he packed the entire hotel so that they would not sleep on the street.

the next day.

Alima touched his aching head, recalling yesterday's scene, and a trace of fear flashed in his heart. His alcohol intake was actually not bad, but facing Liu Mingyu, who was as relaxed as drinking water, he couldn't help shivering.

He swears that in this life, he will never take the initiative to ask Liu Mingyu to drink again, this guy can drink too much.

Brother Xiao Ma was not much better. The first thing he did when he woke up was to swear that he would never ask Liu Mingyu to drink again next time.

In fact, it's not just the two of them. Many people who witnessed the battle last night couldn't help shivering when they thought of that scene.

Liu Mingyu was in high spirits. He got up early in the morning, and after finishing his routine homework and brushing tasks, he also found two horses to have breakfast.

Both horses are busy people. This time, they were able to participate in the celebration banquet of Xingchen Pharmaceutical because they happened to be nearby. After breakfast, they left in a hurry.

The news of the sky-high auction is still hot on the Internet. Depending on the situation, it will not go down in a few days.

All the winning companies or individuals put the money into the account of Xingchen Pharma the next morning, for fear of being slower and kicked out by Xingchen Pharma.

Zhang Guoqing informed Liu Mingyu this morning about Ito Pharmaceutical's automatic price increase.

After Liu Mingyu heard it, he was also surprised, and then relieved.

The other party did not know that they had decided to supply them at the previously agreed price. They were afraid that Xingchen Pharmaceutical would go back on it and automatically increase the price, which was also excusable.

In this regard, Xingchen Pharmaceutical has taken the initiative.

For Ito Pharmaceutical's independent increase of agency fees, Liu Mingyu naturally accepted it with a smile.

The other party gave him money, why not, and this is also a normal price, so it is not a loss for the other party to give this price.

Zhang Guoqing went through the formalities for them immediately.

That afternoon, Nakaki Murakami, who received the notice, immediately rushed to Xingchen Pharmaceutical, holding the contract signed and sealed by both parties, and he let go of his dangling heart.

At last there is an explanation.

For the next period of time, Xingchen Pharmaceutical was busy signing contracts with various companies.

After signing the contract, Xingchen Pharma immediately provided them with general cancer drugs.

Although the current production of cancer generic drugs is limited, there is no problem in giving them a little.

Compared with Huaxia, the international consumption is less than 1% of the output, which has no significant impact at all.

In fact, most of the companies that can immediately obtain general medicines for cancer are Asian yellow races, and people of other skin colors still need to conduct clinical trials.

For the clinical trials of blacks and whites, Xingchen Pharma has not broken its promise.

Clinical trials on blacks and whites were immediately carried out.

Naturally, this experiment does not need to be like the previous one. In a Phase II and Phase III clinical trial, the total number of cases exceeded 10,000.

According to the normal ratio, this time, one hundred people were selected for the experiment.

When conducting clinical trials, Xingchen Pharmaceutical did not break its promise, and announced on its official website a statement on joint experiments with Pfizer.

It seems to be a joint experiment of the two companies, but in fact, everyone knows that the experiments are basically controlled by Xingchen Pharmaceutical.

For such an important drug, it is impossible for Xingchen Pharmaceutical to involve Pfizer. Even if they know that there is no raw stone of life, it is impossible for them to produce a universal drug for cancer treatment.

Pfizer also has self-awareness. Their purpose is not to really participate in the experiment, but to comfort those shareholders with a cooperation quota and comfort those shareholders.

I don't know if they are really blind or deliberately blind.

After Xingchen Pharmaceutical issued a statement, Pfizer's share price, which had already been cut in half, immediately jumped up by nearly 20%.

Unlike Shanghai stocks, U.S. stocks do not have a 10% increase limit, which means that if Pfizer is a little more aggressive, it may not return to its previous market value within a day.

Seeing that Pfizer's share price rose like a rocket, maybe those shareholders and those shareholders didn't really understand it, but they needed this excuse to make the share price rise again.

Before Pfizer's decline, its market value once exceeded 200 billion US dollars, and then it slashed to less than 60 billion US dollars. This fearful decline is no wonder that Pfizer is panicked, and would rather spend a lot of money to engage with Xingchen Pharmaceuticals. contact on.

Everyone now knows that Xingchen Pharmaceutical is a hot company, and it has developed a universal drug for cancer treatment, and it has made more money than all pharmaceutical companies in an auction.

In the past, Pfizer considered itself to be the leader in the hospital industry, but now he only dares to be the second, not the first.

Pfizer's $500 million purchase of a partnership is quite worth it.

By the time the market closed, Pfizer had risen by 40% on the day, and its market value had returned to $100 billion.

Just this increased amount has already made a lot of money.

Although Pfizer is still only half of what it was at its peak, all shareholders can see that it is not far off when it once again stands at $200 billion.

The increase doesn't need to be too big, a 10% increase every day is enough for seven or eight days.

If Pfizer makes big profits, then Ito Pharmaceuticals is not bad either.

Ito Pharmaceutical belongs to the Ito Group. The market value of Ito Pharmaceutical is not as high as that of Pfizer Pharmaceuticals. At its peak, it was only a little over 100 billion US dollars.

However, this time Ito Pharmaceutical announced to the outside world the exclusive agency rights of Neon Country signed with Xingchen Pharmaceutical, and the share price of Ito Pharmaceutical also rose.

The increase is far more exaggerated than that of Pfizer.

On the day of the announcement, Ito Pharma’s stock price returned to its peak.

No, it is another peak, reaching 111 billion US dollars.